Tag: thomson-reuters
-
UK agency backs cancer drug after Sanofi cuts price
LONDON (Reuters) – Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount. The National Institute for Health and Care Excellence (NICE) said the improved discount was “an excellent example of how pharma companies…
-
Better mental health treatment would boost nations’ economies: WHO
By Alex Whiting LONDON (Thomson Reuters Foundation) – Every dollar spent on better treatment of anxiety and depression produces a return of $4 in better health and ability to work – a big boost for countries' development and economic growth, the World Health Organization said on Tuesday. Common mental disorders such as anxiety and depression…
-
Vegetable fat not the route to a healthy heart, study finds
Replacing animal fat in the human diet with vegetable oil seems not to lower heart disease risk, and might even boost it, according to a study published Wednesday that challenges a cornerstone of dietary advice. Switching from saturated to unsaturated Omega-6 fats did result in lower blood cholesterol in a trial with nearly 10,000 participants,…
-
Bhutan tackles violence against women for ‘refusing sex, burning the dinner’
By Saraswati Sundas THIMPHU (Thomson Reuters Foundation) – Sonam Zangmo endured abuse at the hands of her husband for two years before finally walking out on him after the birth of her daughter. “I want my daughter to have a good life.” But without drastic changes in attitudes toward women in the tiny Himalayan nation…
-
Climate impact predicted to cause 500,000 extra deaths in 2050
By Magdalena Mis LONDON (Thomson Reuters Foundation) – Climate change could cause significant changes to global diets, leading to more than half a million extra deaths in 2050 from illnesses such as stroke, cancer and heart disease, experts said on Wednesday. As extreme weather such as floods and heat waves wreaks havoc with harvests and…
-
Redemption in Liberia: a hospital’s painful recovery from Ebola
By Kieran Guilbert MONROVIA (Thomson Reuters Foundation) – The cries of young children ring around the hospital as hundreds of patients, packed tightly together on wooden benches and surrounded by boxes of syringes piled high, wait to be seen. Nurses shout to be heard as they rush through the dimly-lit corridors, past peeling, faded posters…
-
Canadian cross-border M&A seen gaining momentum in 2016
By John Tilak and Euan Rocha TORONTO (Reuters) – Lawyers expect cross-border deals to again drive Canadian merger and acquisition activity in 2016 after aggressive moves by Canadian firms spurred a major surge in M&A transactions last year. Osler, Hoskin & Harcourt topped the list of law firms that advised on M&A transactions involving Canadian…
-
AstraZeneca’s potential $3 billion cancer pill wins early approval
By Ben Hirschler LONDON (Reuters) – A new lung cancer pill from AstraZeneca, designed for patients whose disease has worsened after treatment with other therapies, won early U.S. approval on Friday, in a boost for the British drugmaker. Tagrisso, also known as AZD9291, is one of several cancer medicines AstraZeneca hopes will rebuild its sales…
-
Wife Donates Kidney to Ailing Husband
Meghan White turned out to be a perfect match for her husband, in more ways than one.
-
Sierra Leone girls forced into "degrading" pregnancy tests after school ban
By Kieran Guilbert DAKAR (Thomson Reuters Foundation) – Schoolgirls in Sierra Leone have been forced to undergo humiliating and degrading public pregnancy tests since the government banned pregnant girls from attending mainstream schools and taking exams, Amnesty International said on Friday. A ban on pregnant girls attending school has informally existed for a decade, but…